Kurzrock R - Search Results

1

Survival of 1,181 patients in a phase I clinic: the MD Anderson Clinical Center for targeted therapy experience.

Wheler J, Tsimberidou AM, Hong D, Naing A, Falchook G, Piha-Paul S, Fu S, Moulder S, Stephen B, Wen S, Kurzrock R. Wheler J, et al. Among authors: kurzrock r. Clin Cancer Res. 2012 May 15;18(10):2922-9. doi: 10.1158/1078-0432.CCR-11-2217. Epub 2012 Mar 27. Clin Cancer Res. 2012. PMID: 22452943 Free PMC article.

2

Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.

Kurzrock R, Redman J, Cabanillas F, Jones D, Rothberg J, Talpaz M. Kurzrock R, et al. Cancer Res. 1993 May 1;53(9):2118-22. Cancer Res. 1993. PMID: 8481913

3

The M.D. Anderson Cancer Center experience with interferon-alpha therapy in chronic myelogenous leukaemia.

Talpaz M, Kantarjian HM, O'Brien S, Kurzrock R. Talpaz M, et al. Among authors: kurzrock r. Baillieres Clin Haematol. 1997 Jun;10(2):291-305. doi: 10.1016/s0950-3536(97)80008-x. Baillieres Clin Haematol. 1997. PMID: 9376665 Review. No abstract available.

4

Cytokine deregulation in hematological malignancies: clinical and biological implications.

Kurzrock R. Kurzrock R. Clin Cancer Res. 1997 Dec;3(12 Pt 2):2581-4. Clin Cancer Res. 1997. PMID: 9815659 Review.

5

Chronic myelogenous leukemia--progress at the M. D. Anderson Cancer Center over the past two decades and future directions: first Emil J Freireich Award Lecture.

Kantarjian HM, Talpaz M, O'Brien S, Kurzrock R, Gutterman J, Keating MJ, McCredie KB, Freireich EJ. Kantarjian HM, et al. Among authors: kurzrock r. Clin Cancer Res. 1997 Dec;3(12 Pt 2):2723-33. Clin Cancer Res. 1997. PMID: 10068280 Review.

6

A phase I study of recombinant interferon-beta in patients with advanced malignant disease.

Ravandi F, Estrov Z, Kurzrock R, Breitmeyer JB, Maschek BJ, Talpaz M. Ravandi F, et al. Among authors: kurzrock r. Clin Cancer Res. 1999 Dec;5(12):3990-8. Clin Cancer Res. 1999. PMID: 10632330 Clinical Trial.

7

Phase II study of alemtuzumab in chronic lymphoproliferative disorders.

Ferrajoli A, O'Brien SM, Cortes JE, Giles FJ, Thomas DA, Faderl S, Kurzrock R, Lerner S, Kontoyiannis DP, Keating MJ. Ferrajoli A, et al. Among authors: kurzrock r. Cancer. 2003 Aug 15;98(4):773-8. doi: 10.1002/cncr.11551. Cancer. 2003. PMID: 12910522 Free article. Clinical Trial.

8

Phase II study of pentostatin in advanced T-cell lymphoid malignancies: update of an M.D. Anderson Cancer Center series.

Tsimberidou AM, Giles F, Duvic M, Fayad L, Kurzrock R. Tsimberidou AM, et al. Among authors: kurzrock r. Cancer. 2004 Jan 15;100(2):342-9. doi: 10.1002/cncr.11899. Cancer. 2004. PMID: 14716770 Free article. Clinical Trial.

9

Activity of interferon-alpha and isotretinoin in patients with advanced, refractory lymphoid malignancies.

Tsimberidou AM, Giles F, Romaguera J, Duvic M, Kurzrock R. Tsimberidou AM, et al. Among authors: kurzrock r. Cancer. 2004 Feb 1;100(3):574-80. doi: 10.1002/cncr.20009. Cancer. 2004. PMID: 14745875 Free article.

10

Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis.

Ebrahimi B, Tucker SL, Li D, Abbruzzese JL, Kurzrock R. Ebrahimi B, et al. Among authors: kurzrock r. Cancer. 2004 Dec 15;101(12):2727-36. doi: 10.1002/cncr.20672. Cancer. 2004. PMID: 15526319 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,007 results

Search Page

Filters